financetom
Business
financetom
/
Business
/
BHP says Anglo American rejected $42.7 billion revised proposal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BHP says Anglo American rejected $42.7 billion revised proposal
May 13, 2024 5:39 AM

LONDON (Reuters) -BHP Group ( BHP ) said on Monday that Anglo American had rejected a revised buyout offer valuing the company at 34 billion pounds ($42.67 billion).

Anglo American in April rebuffed BHP's $39 billion all-share takeover proposal, saying it was opportunistic and significantly undervalued its prospects.

"BHP is disappointed that the Anglo American Board has chosen not to engage with BHP with respect to the Revised Proposal and the improved terms," it said in a statement.

"BHP continues to believe that a combination of the two businesses would deliver significant value for all shareholders," it added.

($1 = 0.7968 pounds)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Sarepta Therapeutics' Elevidys Under Investigation by US FDA Following Patient Deaths
Sarepta Therapeutics' Elevidys Under Investigation by US FDA Following Patient Deaths
Jun 25, 2025
07:35 AM EDT, 06/25/2025 (MT Newswires) -- Sarepta Therapeutics ( SRPT ) gene therapy, Elevidys, is being investigated by the US Food and Drug Administration following reports of two deaths after receiving the treatment, multiple media outlets reported Tuesday, citing the FDA. The investigation comes amid safety concerns after the company reported the second death earlier this month of a...
Santander Bank to Sell Seven Branches to Community Bank
Santander Bank to Sell Seven Branches to Community Bank
Jun 25, 2025
07:33 AM EDT, 06/25/2025 (MT Newswires) -- Santander Bank (SAN) said Wednesday that it has agreed to sell seven branches in the Allentown, Pennsylvania, area to Community Financial System ( CBU ) unit Community Bank. The deal is slated to be completed in Q4, Santander said. Santander said it plans to maintain its physical and digital investments, focusing on its...
Gilead Sciences, Kymera Therapeutics to Collaborate on Cancer Program
Gilead Sciences, Kymera Therapeutics to Collaborate on Cancer Program
Jun 25, 2025
07:35 AM EDT, 06/25/2025 (MT Newswires) -- Gilead Sciences ( GILD ) and Kymera Therapeutics ( KYMR ) said Wednesday they have signed an exclusive option and license agreement to develop and commercialize a new molecular glue degrader program targeting cyclin-dependent kinase 2, a key driver of tumor growth. Under the deal, Kymera could receive up to $750 million, including...
Copyright 2023-2026 - www.financetom.com All Rights Reserved